Navigation Links
DePuy ASR Lawsuit Update: Rottenstein Law Group LLP Responds to J&J $3 Billion Settlement Report
Date:8/21/2013

(PRWEB) August 21, 2013

Johnson & Johnson is reportedly considering a more than $3 billion DePuy ASR hip implant settlement, according to Bloomberg.* The Rottenstein Law Group LLP, a metal-on-metal hip implant firm, comments on the news and notes that DePuy hip settlements could amount to more than $300,000 per plaintiff.

There are more than 8,000 DePuy ASR lawsuits pending in federal court alone, according to Bloomberg. Johnson & Johnson said in the story it wants to resolve all federal and state cases by early next year. In 2010 Johnson & Johnson recalled 93,000 metal-on-metal hip implants worldwide, about 37,000 of those in the United States, the story said. The ASR had a failure rate of 12 percent after five years.

“There are a handful of ASR bellwether trials coming up this fall and winter,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “It will be interesting to see how they affect this proposed settlement. Ultimately, though, this is a good sign for those looking to file DePuy lawsuits. There is the potential to receive certain compensation for harms suffered as a result of the alleged side effects of the device.”

The ASR, like some other metal-on-metal hip implants, has been under the lens of the U.S. Food and Drug Administration, chiefly because of one dangerous, alleged adverse side effect called “metal poisoning,” or “metallosis.” According to the FDA, cobalt and chromium particles could enter into the implantee’s bloodstream when the device’s metal parts touch each other. This could lead to potentially severe health problems, the FDA said, such as neurological impairment.**

The Rottenstein Law Group LLP represents clients in ASR hip lawsuits. The firm encourages those who believe they have suffered from the ASR’s alleged side effects to visit the firm’s FAQ page to learn more about lawsuits and settlements.

*bloomberg.com/news/2013-08-21/j-j-said-to-weigh-3-billion-settlement-of-its-hip-implant-cases.html (Aug. 12, 2013)

**http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

Read the full story at http://www.prweb.com/releases/depuy-asr-lawsuit/depuy-settlements/prweb11048548.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Possible August 2013 Deadline Ahead for North Carolina DePuy ASR Hip Recall Lawsuits, Product Liability Lawyer Ben Cochran Says
2. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Most Recent Developments in New Jersey DePuy ASR Recall Litigation
3. Plaintiff Furnishes Witness List for First Trial in DePuy ASR Multidistrict Litigation, Reports Parker Waichman LLP
4. US Drug Watchdog Urges Recalled DePuy ASR Hip Implant Recipients To Call Them Immediately If They Live In A State Where The Statute Of Limitations Has Not Yet Run Out
5. New DePuy Metal Hip Implant Lawsuits Allegations Update: Resource4thePeople Reports Important Trial Scheduled in Federal Consolidated Cases
6. DePuy ASR Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Pre-trial Ruling in Federal DePuy ASR Recall Litigation
7. DePuy ASR Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Release of New Pretrial Order in New Jersey DePuy ASR Recall Litigation
8. DePuy ASR Lawsuit News: Rottenstein Law Group LLP Comments on Judge’s Decision to Exclude 2010 ASR Recall from Trial
9. DePuy Pinnacle Hip Lawsuit Filings in Federal Multidistrict Litigation Exceed 4,600, Bernstein Liebhard LLP Reports
10. DePuy Hip Class I Recall Announced By FDA of Its DePuy LPS Lower Extremity Dovetail Intercalary Hip Implant Component Due to Risk of Fracturing, Reports Wright & Schulte
11. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes DePuy Orthopaedic’s Motion for Summary Judgment in California Bellwether Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between ... they no longer use or need, from clothes to couches to dressers and bicycles. ... and take them to the nearest Goodwill donation center through February 28th. , ...
(Date:1/20/2017)... Miami, Florida (PRWEB) , ... January 20, 2017 , ... ... in head lice cases in families with school-aged children since the holiday season. ... spend the holidays with their families, sharing hugs and taking photos, which is the ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... its sugar-free alternative VW+ 002. The drinks have been produced in collaboration with ... to perform during your workout. , After a successful launch in Sweden last ...
(Date:1/20/2017)... ... 2017 , ... D R Burton Healthcare Products LLC, makers ... in a study indicating superior performance against competitive products in secretion clearance. ... Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter issue ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: an ... of published author, Keith C. A. Tucker, son of Minister Delores Pinnock and a ... by Reverend Mark Hardy , “While sitting up in bed, I felt a pounding ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
Breaking Medicine Technology: